CN102641477A - Medicament for treating pancreatic cancer - Google Patents

Medicament for treating pancreatic cancer Download PDF

Info

Publication number
CN102641477A
CN102641477A CN2012101460272A CN201210146027A CN102641477A CN 102641477 A CN102641477 A CN 102641477A CN 2012101460272 A CN2012101460272 A CN 2012101460272A CN 201210146027 A CN201210146027 A CN 201210146027A CN 102641477 A CN102641477 A CN 102641477A
Authority
CN
China
Prior art keywords
herba
radix
pancreatic
pancreatic cancer
pancreas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101460272A
Other languages
Chinese (zh)
Inventor
许俊斋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101460272A priority Critical patent/CN102641477A/en
Publication of CN102641477A publication Critical patent/CN102641477A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating pancreatic cancer. The medicament has a relatively high curative effect, and the effective rate of the medicament for treating the pancreatic cancer can reach more than 90%. The pancreatic cancer is relatively infrequent in malignant tumors of alimentary tract. According to modern medicine, patients subjected to benign pancreatic cancer are less, malignant pancreatic cancer accounts for 10% of malignant tumors and mainly occurs in groups at the age of 40 to 60, men suffering from the malignant pancreatic cancer are 4 times more than women suffering from that, and the pancreatic cancer mainly occurs at a pancreatic head and rarely occurs at a pancreatic body and a pancreatic tail part. Most of the pancreatic cancers come from the epithele of a pancreatic duct. The benign pancreatic tumor is possibly subjected to canceration. The pancreatic cancer is relatively rapid in development, easy to transfer and relatively short in disease course.

Description

A kind of medicine of treating cancer of pancreas
The present invention relates to a kind of medicine of treating cancer of pancreas.
At present existing treatment treatment cancer of pancreas is prefered method with modern medicine to treatment 1, the operative treatment of primary disease mainly, can excise in the lump together with spleen and duodenum sometimes, can carry out gastrointestinal tract during all can not excision and coincide or cholecystostomy.2, radiotherapy, chemotherapy are all insensitive, chemotherapy solaziquonum commonly used and fluorouracil.Primary disease belongs to " lump in the abdomen " more, gathers at tcm clinical practice, " jaundice " category.
The medicine that the purpose of this invention is to provide a kind of effective auxiliary treatment cancer of pancreas.Curative effect of the present invention is high, and effective percentage can reach more than 90%.
The present invention adopts following principle to realize: cancer of pancreas is relatively more rare in malignant tumor of digestive tract; Modern medicine thinks that optimum person is few for pancreas tumor, and pernicious pancreas carninomatosis accounts for 10% of malignant tumor; Be more common in 40-60 year; The man is Duoed 4 times than the woman, and cancer of pancreas mostly occurs in head of pancreas portion, and only minority occurs in body of pancreas and tail of pancreas portion.Most cancer of pancreas are from the glandular tube epithelium.The optimum adenoma of assisting also possibly cancerate.The primary disease development is very fast, the easy transfer.The course of disease is shorter.
Modern medicine is thought the primary disease etiology unknown.Maybe with carcinogen in the environment, (industrial chemistry material), coffee, smoking is relevant with chronic pancreatic diseases, air pollution, the seven emotions and the six sensory pleasures, long-term pessimistic, unlucky self-distrust, sigh in despair, autoimmune ability drop, institute such as long-term flu.Cancer of pancreas is because the morning and evening of the position that cancerous protuberance takes place and the course of disease is different, and prison bed sings and symptoms is also different.How not obvious early symptom is, and majority has anorexia and loses weight, the symptom of suffering from abdominal pain and occurring into the earliest.Be more common in body of pancreas and tail of pancreas portion, be positioned at epigastrium, carcinoma of head of pancreas can be partial to upper right abdomen, and body of pancreas tail cancer can be partial to upper right abdomen.Pain is angor, paroxysmal or persistence, the dull pain that carrying out property increases the weight of, big multidirectional lower back radiation increases the weight of in clinostatism and evening, sit stand, lean forward the position or when walking about pain can subtract.The progress of the course of disease can have jaundice, the carcinoma of head of pancreas jaundice is more sees, and occurs early, and many no jaundice jaundice occurred and are mostly late period when cancerous protuberance was confined to body of pancreas, afterbody.Jaundice belongs to obstructive more, is carrying out property and increases the weight of, and is the pus Huang with skin pruritus, urine, and stool is canescence, loses weight and increases the weight of day by day.Weak very common with inappetence, can be with the diarrhoea constipation, abdominal distention is felt sick.Late period occurring abdominal mass, heating, supraclavicular lymph nodes is modal metastasis site.
Primary disease is diagnosed main foundation:
1, clinical symptoms, Signs: pancreas B-type ultrasonography CT, can show irregular enlargement of pancreas and gallbladder enlargement, make a definite diagnosis value in conjunction with FNA cytolgical examination under the B ultrasonic guiding.
2, laboratory examination: the VDB direct reaction is positive in the blood, and Urobilin increases, and stercobilin and Urobilin do not have shortage.Serum neutral and alkali phosphatase and pancreatin activity increase all meaningful.Find cancerous cell during duodenum drain smear.
3, X ray examination, plain film or see soft tissue shadows, carcinoma of head of pancreas can show duodenum Qu Zengkuan, or the duodenum compressive deformation, the resembling of stenosis of bowel and pylorus pressurized.Body of pancreas and carcinoma of tail of pancreas can show the filling defect or the gastrointestinal displacement of lesser gastric curvature and body of stomach rear wall pressurized sometimes.
4, biopsy: be the reliable method of distinguishing pancreas tumor, diseases such as the appropriate to the occasion attention choledocholithiasis of Differential Diagnosis, chronic pancreatitis, acute icterohepatitis, primary hepatic carcinomas.
Motherland's medical science is thought depression of liver-QI, and functional activity of QI being not smooth is so see that stomachache, gastral cavity abdomen are uncomfortable, distension, hyperactive liver-QI attacking the spleen, deficiency-weakness of spleen-QI; So see inappetence, it is weak to become thin, diarrhoea, and insufficiency of the spleen resulting in production of dampness, the damp-stagnancy heat-transformation is held in the pyretic toxicity; Then send out and be jaundice, with the passing of time the course of disease delays, qi depression to blood stasis, and knot is then seen the abdomen piece in the pyretic toxicity.The present invention adopts multiple rare Chinese medicine reasonable compatibility, is the main purpose that reaches the recovery from illness of treatment Pancreas cancer patients life with the benefit.
Owing to taked such scheme, can make the present invention's treatment cancer of pancreas curative effect high, effective percentage can reach more than 90%.
Below be detailed prescription of the present invention and processing technology: (1) Herba Hyperici Japonici, Hypericaceae: bitter, flat.Heat-clearing and toxic substances removing, promoting blood circulation and detumescence is controlled pancreas cancer 15-30g.
(2) Radix Gei japonici, Rubiaceae: hardship, the root of Dahurian angelica, cold, heat-clearing and toxic substances removing, eliminating stasis to stop pain, anticancer 15-20g.
(3) Sichuan Herba Dendrobii, the orchid family: sweet, light, little, cold.Reinforcing stomach reg fluid, replenishing YIN and removing heat.Anticancer 5-15g.
(4) Herba Selaginellae Doederleinii, Selaginaceae: sweet, flat.Heat-clearing and toxic substances removing, anticancer 15-20g.
(5) Rhizoma Atractylodis Macrocephalae, Compositae: sweet, bitter, warm, invigorating the spleen and replenishing QI, dampness diuretic, strengthening superficial resistance to stop perspiration, 15g.
(6) Radix Paeoniae Alba, Ranunculaceae: bitter, acid, be slightly cold.Suppressing liver-YANG, the yin fluid astringing that nourishes blood, easing the affected liver hemostasis, anticancer 13g.
(7) Radix Ampelopsis, Vitaceae: bitter, hot, be slightly cold.Heat-clearing and toxic substances removing, the pain that disappears is swollen.Anticancer 3-9g.
(8) Spica Prunellae, Labiatae: bitter, cold.Heat-clearing and toxic substances removing, the removing heat from blood detumescence.Anticancer 10-15g.
(9) Radix Scrophulariae, Scrophulariaceae: bitter, one-tenth, cold.Clearing away heat and nourishing YIN, detoxicating and resolving stagnation of pathogens.Anticancer therapy malignant tumor 10-15g.
(10) Herba Lobeliae Chinensis, campanulaceae: sweet, light, be slightly cold.Inducing diuresis to remove edema, cancer of pancreas 9-15g is controlled in detoxifcation.
(11) Herba Scutellariae Barbatae, Labiatae: hot, bitter, cold.Heat-clearing and toxic substances removing, diuresis, treating the liver gallbladder 10-30g.
(12) Herba Hedyotidis Diffusae, madder former times section: bitter, sweet, cold, heat-clearing and toxic substances removing, dissipating blood stasis dampness removing, treating the liver intestinal canal tumour 15-30-60g.
(13) Herba Catharanthi Rosei, Apocynaceae: bitter, cool, poisonous, anticancer removing heat from the liver, 9-15g.
(14) Aloe, Liliaceae: bitter, cold.Purging heat to relax the bowels, the cool liver of parasite killing, 1-2g.
(15) Radix Paeoniae Rubra, Ranunculaceae: bitter, be slightly cold.Clearing away heat and cooling blood, promoting blood circulation to remove blood stasis is controlled cancer of pancreas 3-15g.
(16) Fructus Forsythiae, Oleaceae: bitter, be slightly cold.Heat-clearing and toxic substances removing, anticancer 9-15g.
(17) Cortex Moutan, Ranunculaceae: hot, bitter, be slightly cold.Clearing away heat and cooling blood, promoting blood circulation to remove blood stasis 6-15g.
(18) Semen Astragali Complanati, pulse family: sweet, warm, invigorating the liver and kidney, controlling nocturnal emission with astringent drugs makes eye bright.Treating the liver renal carcinoma 10-20G.
(19) Herba Artemisiae Annuae, Compositae: bitter, cold.Removing summer-heat administration heat, reducing the asthenic fever, 3-9g.
(20) Fructus Psoraleae, pulse family: hot, bitter, big temperature.Invigorating the liver and kidney, supporing yang antidiarrheal, 15g.
(21) Wild Ganoderma, Cordycepps: porous, sweet, tepor.QI replenishing and blood tonifying, tranquilizing by nourishing the heart, relieving cough and asthma, 6-15g.
(22) Radix Curcumae, Zingiberaceae: hot, bitter, cold.Removing heat from blood clears away heart-fire, promoting QI circulation for relieving depression, function of gallbladder promoting, jaundice eliminating, treating the liver pancreas tumor, 15g.
(23) Rhizoma Polygoni Cuspidati, Polygonaceae: bitter, cold.Wind-damp dispelling is invigorated blood circulation, and heat-clearing and toxic substances removing is controlled tripe pancreas cancer 10-30g.
(24) Herba Lysimachiae, Primulaceae: little one-tenth, flat.The dehumidifying jaundice eliminating, relieving stranguria by diuresis, clearing heat for detumescence, treating the liver pancreas tumor 15-60g.
(25) Herba Sarcandrae, golden Li Lanke: hot, bitter, flat.Slightly poisonous, heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis is controlled cancer 10-15g.
(26) Picrorhiza scrophulariiflora 3-10g; Herba Duchesneae Indicae 10-20g; China ink Herba Ecliptae 30g; Artemisia anethoicles Mattf 10-15g; Beauty Jiao Gen 30g; Folium cordylines fruticosae 30g; Concha Ostreae (calcined) 30g; Radix Salviae Miltiorrhizae 20g; Spica Prunellae 30g; Radix Angelicae Sinensis 15g; Radix Codonopsis 15g; Fructus Toosendan 12g; Radix Cynanchi Paniculati 15g; PORIA from Yunnan of China 20g; Semen Persicae 12g; Stir-baked SQUAMA MANITIS 12g; Carapax Trionycis (processed) 20g; Semen Vaccariae 12g; Herba cassiae occidentalis 12g; Herba Plantaginis 20g; Rhizoma Saururi (Herba Saururi) 20g; Semen Coicis 20g; Radix Astragali 30g; Radix Aucklandiae 9g; Radix Pseudostellariae 15g; Taraxacum 30g; Flos Chrysanthemi Indici 15g; RHIIZOMA DIOSCOREAE frOm Henan of China 30g.
Above medicine according to Chinese medicine concocting method individual processing, then is processed into powder.Instructions of taking: take the 10-20 gram every day three times, boiled water is taken after mixing it with water after 30 minutes after meal at every turn.

Claims (1)

1. medicine of treating cancer of pancreas is characterized in that it is made up of than component following weight: Radix Gei japonici 15-20g, Sichuan Herba Dendrobii 5-15g, Herba Selaginellae Doederleinii 15-20g, Rhizoma Atractylodis Macrocephalae 15g, Radix Paeoniae Alba 13g, Radix Ampelopsis 3-9g, Spica Prunellae 10-15g, Radix Scrophulariae 10-15g, Herba Lobeliae Chinensis 9-15g, Herba Scutellariae Barbatae 10-30g, Herba Hedyotidis Diffusae 15-30-60g, Herba Catharanthi Rosei 9-15g, Aloe 1-2g, Radix Paeoniae Rubra 3-15g, Fructus Forsythiae 9-15g, Cortex Moutan 6-15g, Semen Astragali Complanati 10-20g, Herba Artemisiae Annuae 3-9g, Fructus Psoraleae 15g, Wild Ganoderma 6-15g, Radix Curcumae 15g, Rhizoma Polygoni Cuspidati 10-30g, Herba Lysimachiae 15-60g, Herba Sarcandrae 10-15g, Picrorhiza scrophulariiflora 3-10g, Herba Duchesneae Indicae 10-20g, black Herba Ecliptae 30g, Artemisia anethoicles Mattf 10-15g, beauty Jiao Gen 30g, Folium cordylines fruticosae 30g, Concha Ostreae (calcined) 30g, Radix Salviae Miltiorrhizae 20g, Spica Prunellae 30g, Radix Angelicae Sinensis 15g, Radix Codonopsis 15g, Fructus Toosendan 12g, Radix Cynanchi Paniculati 15g, PORIA from Yunnan of China 20g, Semen Persicae 12g, stir-baked SQUAMA MANITIS 12g, Carapax Trionycis (processed) 20g, Semen Vaccariae 12g, Herba cassiae occidentalis 12g, Herba Plantaginis 20g, Rhizoma Saururi (Herba Saururi) 20g, Semen Coicis 20g, Radix Astragali 30g, Radix Aucklandiae 9g, Radix Pseudostellariae 15g, Taraxacum 30g, Flos Chrysanthemi Indici 15g, RHIIZOMA DIOSCOREAE frOm Henan of China 30g.
CN2012101460272A 2012-05-14 2012-05-14 Medicament for treating pancreatic cancer Pending CN102641477A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101460272A CN102641477A (en) 2012-05-14 2012-05-14 Medicament for treating pancreatic cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101460272A CN102641477A (en) 2012-05-14 2012-05-14 Medicament for treating pancreatic cancer

Publications (1)

Publication Number Publication Date
CN102641477A true CN102641477A (en) 2012-08-22

Family

ID=46654719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101460272A Pending CN102641477A (en) 2012-05-14 2012-05-14 Medicament for treating pancreatic cancer

Country Status (1)

Country Link
CN (1) CN102641477A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127485A (en) * 2013-03-07 2013-06-05 孙文娟 Medicine for treating tumors
CN103330833A (en) * 2013-06-24 2013-10-02 顾燕君 Traditional Chinese medicine for treating great occipital neuralgia
CN103611091A (en) * 2013-12-11 2014-03-05 东莞市圣虹生物科技有限公司 Traditional Chinese medicine composition for treating pancreatic cancer
CN104784508A (en) * 2015-04-20 2015-07-22 李萌 Method for preparing traditional Chinese medicine preparation for improving immunity of malignant tumor patient
EP2952184A1 (en) * 2014-06-04 2015-12-09 China Medical University Pharmaceutical formulation for treating pancreatic cancer

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127485A (en) * 2013-03-07 2013-06-05 孙文娟 Medicine for treating tumors
CN103330833A (en) * 2013-06-24 2013-10-02 顾燕君 Traditional Chinese medicine for treating great occipital neuralgia
CN103611091A (en) * 2013-12-11 2014-03-05 东莞市圣虹生物科技有限公司 Traditional Chinese medicine composition for treating pancreatic cancer
CN103611091B (en) * 2013-12-11 2016-04-27 东莞市东卓中天生物科技有限公司 A kind of Chinese medicine composition for the treatment of cancer of pancreas
EP2952184A1 (en) * 2014-06-04 2015-12-09 China Medical University Pharmaceutical formulation for treating pancreatic cancer
US9872912B2 (en) 2014-06-04 2018-01-23 China Medical University Method for treating pancreatic cancer
CN104784508A (en) * 2015-04-20 2015-07-22 李萌 Method for preparing traditional Chinese medicine preparation for improving immunity of malignant tumor patient

Similar Documents

Publication Publication Date Title
CN103705897B (en) A kind of cancer relieves the pain plaster
CN103550517A (en) Medicine for treating liver cancer
CN103041317A (en) Traditional Chinese medicine composition for treating tumors and preparation method thereof
CN102641477A (en) Medicament for treating pancreatic cancer
CN103550696B (en) Medicine for treating lung cancer
CN103505690A (en) Medicament for treating chronic gastrointestinal tract diseases and preparation method of medicament
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN103007226A (en) Drug for treating hepatocirrhosis ascites, and preparation method thereof
CN101322818B (en) Chinese medicine for treating galactophore lobular hyperplasia
CN102716406A (en) Pill for treating functional diarrhoea
CN104436009A (en) Medicine for treating liver cancer
CN106963796A (en) Treat the Chinese medicine of herpes zoster
CN102698210A (en) Traditional Chinese medicine capable of invigorating spleen and supplementing qi and treating gastroptosis
CN104984267A (en) Traditional Chinese medicine composition for treating lung cancer
CN102327572B (en) Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof
CN103638453A (en) Traditional Chinese medicine for treating tuberculosis
CN103520669A (en) Traditional Chinese medicine for treating phlegm-damp accumulation symptom type chest stuffiness and pains
CN103263587A (en) Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof
CN102920965A (en) Traditional Chinese medicine water-bindered pill for treating advanced lung cancer
CN104857455A (en) Traditional Chinese medicine preparation for chronic interstitial nephropathy and preparation method thereof
CN103690869B (en) Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof
CN102657815A (en) Chinese patent medicine orally-taken pill for treating malignant tumors
CN103272189A (en) Medicine for curing gallstones
CN105617146A (en) Traditional Chinese medicine composition for preventing and treating infantile recurrent respiratory tract infection and preparation method thereof
CN100411681C (en) Medicine for shortening lying-in time and treating artificial abortion sequela

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120822